Eco Animal Health Group deliver strong resilient performance (Interview)

ECO Animal Health Group plc (LON:EAH) has issued a trading update ahead of its Annual General Meeting to be held later today.  The Group reported an exceptional recovery from the African Swine Fever outbreak in China

ECO Animal Health Group plc (LON:EAH) has announced the publication of the following documents on the Company’s website: www.ecoanimalhealthgroupplc.com/investor-relations.aspx. ·    Annual Report and Accounts for the year ended 31 March 2021 ·    Notice of the Annual General Meeting (“AGM”)

ECO Animal Health Group plc (LON:EAH) has announced its results for the year ended 31 March 2021. HIGHLIGHTS Financials · Sales up 46% at £105.6m (2020: £72.1m) · Gross margin increased to 51% (2020: 46%) · Profit before tax

Eco Animal Health Group plc (LON:EAH) has issued a positive update on Group trading and the impact of a strong Chinese market on the business: ·    Group revenue and EBITDA for the year ending 31 March 2021

ECO Animal Health Group plc (LON:EAH) has reported its results for the year ended 31 March 2020. HIGHLIGHTS Financials ·      Sales 7% higher at £72.1m (2019 restated: £67.3m) ·      Gross margin consistent to within 1% (2020 46%, 2019

ECO Animal Health Group plc (LON:EAH) has issued a positive revenue update following the conclusion of its third quarter ended 31 December 2020 and an outlook for the year ending 31 March 2021. ·    Group revenue and

ECO Animal Health Group plc (LON:EAH) has announced that it has received marketing authorisations from the United States Center for Veterinary Medicine of the Food and Drug Administration and from the Veterinary Drugs Directorate of Health Canada for

ECO Animal Health Group plc (LON:EAH) has announced that it has received a marketing authorisation from Brazil’s Ministry of Agriculture, Livestock and Food Supply for Circo/MycoGard®, a vaccine for swine. Circo/MycoGard® is used for the vaccination of

ECO Animal Health Group plc (LON:EAH) has issued a positive trading update following the conclusion of its first six months ended 30 September 2020. ·    Group revenue at the half year ahead of management expectations and prior

ECO Animal Health Group plc (LON:EAH) subsidiary ECO Animal Health Ltd has announced that it has entered two worldwide exclusive research partnerships to develop novel vaccines for use in pigs. These two new partnerships with The

ECO Animal Health Group plc (LON:EAH) has announced that, as anticipated, a marketing authorisation has been received from the European Medicines Agency (EMA) for the use of Aivlosin® 625 mg/g Water Soluble Granules for the treatment

ECO Animal Health Group plc (LON:EAH) has issued a positive trading update today following the conclusion of its financial year ended 31 March 2020. ·    Strong financial performance in the year ended 31 March 2020 ·    Group revenue

ECO Animal Health Group plc (LON:EAH) has today announced that, with effect from 1 May 2020, Dr Frank Armstrong has been appointed as a Non-Executive Director of the Company. Frank brings extensive experience to the Company

ECO Animal Health Group (LON:EAH), today announced that its subsidiary ECO Animal Health Limited has received a marketing authorisation from the Ministry of Agriculture, Directorate General of Livestock and Animal Health of the Republic of Indonesia. The

ECO Animal Health Ltd, a wholly owned subsidiary of ECO Animal Health Group plc (LON:EAH), today announced that it has entered into a second worldwide exclusive research partnership with The Pirbright Institute, United Kingdom, to develop

ECO Animal Health Ltd, a wholly owned subsidiary of ECO Animal Health Group plc (LON:EAH), has today announced that it has entered into a worldwide exclusive research partnership with The Pirbright Institute, United Kingdom, to develop

ECO Animal Health Group Plc (LON:EAH) today announced the appointment of Christopher Wilks as Chief Financial Officer of ECO from 3 September 2019. Marc Loomes, CEO of ECO, commented: “I’m delighted to welcome Chris to our